Clinical Trial Update: Role of Turmeric on Oxidative Modulation in ESRD Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the effect of turmeric extract on oxidative modulation in patients with end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• turmeric extract (curcumin)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: End Stage Renal Failure | Phase 1, Phase 2 | Status: COMPLETED